CD68 and hepatocellular carcinoma: Analysis revealed a significant reduction in the presence of NUPR1+CD68+ cells in patients who responded to immunotherapy compared to those who did not (Figure 7B,C), indicating NUPR1+ macrophages contribute to resistance against HCC immunotherapy.